Recordati's revenue rises 5% in Q1 despite FX impact
29/04/2026 12:06
April 29 (Reuters) - Italian pharmaceutical company Recordati RECI.MI reported on Wednesday a 4.9% rise in its first-quarter net revenue to 713.4 million euros ($834.7 million). The company said its revenue was hit by an adverse impact from foreign exchange (FX) of 29.1 million euros. Recordati will post its full Q1 financial results on May 12, 2026. ($1 = 0.8547 euros) (Reporting by Mirko Miorelli) ((Mirko.miorelli@thomsonreuters.com))
Recent news on Recordati Industria Chimica E Farmaceutica SpA
See all newsBrief: CVC Investor Enters Amendment To Allow Total Return Swap Derivatives In Context Of Takeover Bid On Recordati's Shares
Brief: Recordati Says Italy's Watchdog Consob Suspends Review Period For Approval Of Offer Document
Italy - Factors to watch on June 22
Brief: Respighi BidCo Files With Italy's Market Watchdog Consob Offer Document Related To Tender Offer For Recordati
Press Digest: Wall Street Journal - May 26